Trends of blood pressure control in the US during the COVID-19 pandemic

被引:41
作者
Shah, Nishant P. [1 ,2 ]
Clare, Robert M. [1 ]
Chiswell, Karen [1 ]
Navar, Ann Marie [4 ]
Shah, Bimal R. [2 ,3 ]
Peterson, Eric D. [4 ]
机构
[1] Duke Clin Res Inst, Durham, NC USA
[2] Duke Univ, Sch Med, Div Cardiol, Durham, NC USA
[3] Teledoc Hlth, Purchase, NY USA
[4] Univ Texas Southwestern Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA
关键词
SEASONAL-VARIATION; MORTALITY; METAANALYSIS; ASSOCIATION; DISEASE; RISK;
D O I
10.1016/j.ahj.2021.11.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Importance COVID-19 altered lifestyles and disrupted routine health care. Whether blood pressure (BP) control worsened during COVID-19 is unknown. Objective To understand whether home BP control worsened during COVID-19 across the United States (US) . Design, Setting, and Participants A population-based analysis of home BP data from 72,706 participants enrolled in a digital health hypertension control program. Data was compared before (January 2019 to March 2020) and during (April 2020 to August 2020) COVID-19. Main Outcomes and Measures Monthly mean home BP readings, systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) were quantified before and during the pandemic. Multivariable adjustments were made for age, sex, race, region, and months enrolled. Home BP readings were also classified based on monthly averages and highest home BP readings into risk groups: Stage 2 HTN: BP> = 135 or DBP> = 85; Uncontrolled HTN: SBP >= 145 or DBP >= 95; or Severely uncontrolled HTN: SBP > = 160 or DBP > = 100). Results Overall, 72,706 participants were enrolled in a digital health hypertension program between 1/1/2019 and 8/31/2020. Compared with participants pre-COVID-19 (n = 33,440), those during COVID-19 ( n = 39,266) were of similar age (mean 53.0 +/- 10.7 years vs 53.3 +/- 10.8 years); sex (46% vs 50.6% female) and race (29.1% vs 34.2% non-white). Relative to pre-Covid (Apr-Aug 2019) the mean monthly number of home BP readings rose during COVID-19 (Apr-Aug, 2020), from 7.3 to 9.3 per month (P < .001). During COVID-19, participants had higher monthly adjusted mean SBP (131.6 mmHg vs. 127.5 mmHg, P < .001); DBP (80.2 mmHg vs. 79.2 mmHg, P < .001); and MAP (97.4 mmHg vs. 95.3 mmHg; P < .001). Relative to the pre-pandemic period, during COVID-19 the proportion of participants with a mean monthly BP classified as uncontrolled or severely uncontrolled hypertension also rose, 15% vs 19% and 4% vs 5%, respectively Conclusions and Relevance Based on home BP readings, mean monthly BP rose modestly after COVID-19, despite increased utilization of home monitoring. Further studies are needed to examine the longitudinal effects of the pandemic on cardiovascular disease risk factors, the impact of these on long-term population health.
引用
收藏
页码:15 / 23
页数:9
相关论文
共 29 条
  • [1] Normal ambulatory blood pressure: a clinical practice-based comparison of two recently published definitions
    Ben-Dov, IZ
    Ben-Arie, L
    Mekler, J
    Bursztyn, M
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2005, 19 (07) : 565 - 567
  • [2] SEASONAL-VARIATION IN ARTERIAL BLOOD-PRESSURE
    BRENNAN, PJ
    GREENBERG, G
    MIALL, WE
    THOMPSON, SG
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1982, 285 (6346): : 919 - 923
  • [3] Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality A Systematic Review and Network Meta-analysis
    Bundy, Joshua D.
    Li, Changwei
    Stuchlik, Patrick
    Bu, Xiaoqing
    Kelly, Tanika N.
    Mills, Katherine T.
    He, Hua
    Chen, Jing
    Whelton, Paul K.
    He, Jiang
    [J]. JAMA CARDIOLOGY, 2017, 2 (07) : 775 - 781
  • [4] Population-Attributable Risk for Cardiovascular Disease Associated With Hypertension in Black Adults
    Clark, Donald, III
    Colantonio, Lisandro D.
    Min, Yuan-, I
    Hall, Michael E.
    Zhao, Hong
    Mentz, Robert J.
    Shimbo, Daichi
    Ogedegbe, Gbenga
    Howard, George
    Levitan, Emily B.
    Jones, Daniel W.
    Correa, Adolfo
    Muntner, Paul
    [J]. JAMA CARDIOLOGY, 2019, 4 (12) : 1194 - 1202
  • [5] Deferral of Care for Serious Non-COVID-19 Conditions A Hidden Harm of COVID-19
    DeJong, Colette
    Katz, Mitchell H.
    Covinsky, Kenneth
    [J]. JAMA INTERNAL MEDICINE, 2021, 181 (02) : 274 - 274
  • [6] Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?
    Esler, Murray
    Esler, Danielle
    [J]. JOURNAL OF HYPERTENSION, 2020, 38 (05) : 781 - 782
  • [7] Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
    Ettehad, Dena
    Emdin, Connor A.
    Kiran, Amit
    Anderson, Simon G.
    Callender, Thomas
    Emberson, Jonathan
    Chalmers, John
    Rodgers, Anthony
    Rahimi, Kazem
    [J]. LANCET, 2016, 387 (10022) : 957 - 967
  • [8] Blood pressure categories and long-term risk of cardiovascular disease according to age group in Japanese men and women
    Fujiyoshi, Akira
    Ohkubo, Takayoshi
    Miura, Katsuyuki
    Murakami, Yoshitaka
    Nagasawa, Shin-ya
    Okamura, Tomonori
    Ueshima, Hirotsugu
    [J]. HYPERTENSION RESEARCH, 2012, 35 (09) : 947 - 953
  • [9] Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study
    Gao, Chao
    Cai, Yue
    Zhang, Kan
    Zhou, Lei
    Zhang, Yao
    Zhang, Xijing
    Li, Qi
    Li, Weiqin
    Yang, Shiming
    Zhao, Xiaoyan
    Zhao, Yuying
    Wang, Hui
    Liu, Yi
    Yin, Zhiyong
    Zhang, Ruining
    Wang, Rutao
    Yang, Ming
    Hui, Chen
    Wijns, William
    McEvoy, J. William
    Soliman, Osama
    Onuma, Yoshinobu
    Serruys, Patrick W.
    Tao, Ling
    Li, Fei
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 (22) : 2058 - 2066
  • [10] SEASONAL INFLUENCES ON BLOOD-PRESSURE IN HIGH NORMAL TO MILD HYPERTENSIVE RANGE
    GIACONI, S
    GHIONE, S
    PALOMBO, C
    GENOVESIEBERT, A
    MARABOTTI, C
    FOMMEI, E
    DONATO, L
    [J]. HYPERTENSION, 1989, 14 (01) : 22 - 27